This list is an analysis based on recent market events. It's not an investment recommendation.
About
Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. It develops psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder, as well as devices for the efficient application of medications. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.
The current price of LOBEF is $0.05 USD — it has increased by +9.7% in the past 24 hours. Watch Lobe Sciences stock price performance more closely on the chart.
What is Lobe Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lobe Sciences stocks are traded under the ticker LOBEF.
Is Lobe Sciences stock price growing?▼
LOBEF stock has fallen by -10.32% compared to the previous week, the month change is a +1,011.3% rise, over the last year Lobe Sciences has showed a +104.48% increase.
What is Lobe Sciences market cap?▼
Today Lobe Sciences has the market capitalization of 13.78M
What is Lobe Sciences revenue for the last year?▼
Lobe Sciences revenue for the last year amounts to 0 USD.
What is Lobe Sciences net income for the last year?▼
LOBEF net income for the last year is -6.42M USD.
In which sector is Lobe Sciences located?▼
Lobe Sciences operates in the Health Care sector.
When did Lobe Sciences complete a stock split?▼
The last stock split for Lobe Sciences was on June 10, 2022 with a ratio of 1:6.